Showing results (561-570 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|January 30, 2023
Biosimilarity Assessment of the Biosimilar Teriparatide Candidate and the Reference Drug in Healthy SubjectsXuan Wang, Xintong Liang, Tenghua Wang, et al.
Clinical Pharmacology in Drug Development|November 16, 2022
Evaluation of Potential Food Effects and Drug Interactions With Lansoprazole in Healthy Adult Volunteers Receiving FutibatinibIkuo Yamamiya, Allen Hunt, Fumiaki Yamashita, et al.
Clinical Pharmacology in Drug Development|February 14, 2025
Lack of Pharmacokinetic Drug-Drug Interactions Between Bepirovirsen and Nucleos(t)ide AnalogsKelong Han, Amir S Youssef, Mindy Magee, et al.
Clinical Pharmacology in Drug Development|January 22, 2025
Phase 1 Mass Balance Study of Pizuglanstat: An Investigational Hematopoietic Prostaglandin D Synthase InhibitorRyuzo Hanada, Toru Takenaka
Clinical Pharmacology in Drug Development|January 23, 2025
Evaluation of the Effect of Momelotinib on Cardiac Repolarization: A Thorough QT StudyGeorgios Vlasakakis, Yolanda Alvarez, Timothy Hart, et al.
Clinical Pharmacology in Drug Development|January 20, 2025
Pharmacokinetics and Bioequivalence of 2 Products of Fluticasone Propionate Nasal Spray in Healthy Chinese SubjectsPengkai Wang, Yuan Li, Bing Xu, et al.
Clinical Pharmacology in Drug Development|January 20, 2025
Bioequivalence Study of Bedaquiline Fumarate Tablets in Healthy Chinese SubjectsMan Yang, Yingzi Pei, Chen Chen, et al.
Clinical Pharmacology in Drug Development|November 17, 2024
The Safety, Tolerability, and Pharmacokinetics of Active Ingredients From Hydroxysafflor Yellow A in Healthy Chinese VolunteersXiuli Zhao, Shanye Gu, Xia Wang, et al.
Clinical Pharmacology in Drug Development|November 26, 2024
Pharmacokinetics and Bioequivalence Evaluation of Trazodone Hydrochloride Sustained-Release Tablets in Healthy Chinese VolunteersJingyan Wang, Yuan Xu, Zhicheng Zhao, et al.
Clinical Pharmacology in Drug Development|November 21, 2024
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White ParticipantsAssem El Baghdady, Rocío Lledó-García, Maryam Gayfieva, et al.
Pageof 136